Esperion Therapeutics
ESPR
#6732
Rank
NZ$0.83 B
Marketcap
$4.23
Share price
2.49%
Change (1 day)
115.10%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.63

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.83. In 2022 the company made an earnings per share (EPS) of -$6.08 an increase over its 2021 EPS that were of -$16.36.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.63-23.87%
2022-$6.08-62.87%
2021-$16.3680.38%
2020-$9.0750.14%
2019-$6.04-53.18%
2018-$12.917.41%
2017-$12.02110.81%
2016-$5.7047.35%
2015-$3.870.89%
2014-$3.8328.84%
2013-$2.98-89.3%
2012-$27.82
2002-$11.728.89%
2001-$10.76-83.77%
2000-$66.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$17.53 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.33-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.18-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$63.95-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.10-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.16-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA